Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Aviron's FluMist PLA/ELA deemed nonfilable by FDA; resubmission planned

Sep. 15, 1998

New T-cell kinase inhibitor presented by Abbott at ACS meeting

Sep. 10, 1998

Potent and selective inhibitors of p56lck kinase developed at Celltech

Sep. 9, 1998

Licensing opportunity from the NIH: carrier for conjugate vaccines

Sep. 9, 1998

Licensing and/or CRADA opportunity: drug and method to prevent and treat graft-vs.-host disease

Sep. 8, 1998

Scripps patents guanine derivatives with immunostimulating activity

Sep. 4, 1998

Fujisawa announces marketing approval of Prograf in Mexico and launch in Taiwan

Sep. 3, 1998

Another rotavirus vaccine gives promising results in phase II testing

Sep. 3, 1998

FDA approves first vaccine for prevention of rotaviral disease

Sep. 1, 1998

Genset enters into Chlamydia vaccine license agreement with AHP

Aug. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...